<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105031/" ref="ordinalpos=3784&amp;ncbi_uid=3005440&amp;link_uid=PMC3105031" image-link="/pmc/articles/PMC3105031/figure/pone-0020362-g006/" class="imagepopup">Figure 6. Proposed model of the p53−miR-34−E2F1−h-eag1 <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>..  From: Transcriptional and Post-Transcriptional Mechanisms for Oncogenic Overexpression of Ether À Go-Go K+ Channel. </a></div><br /><div class="p4l_captionBody">RA: retinoic acid, which has been shown to enhance miR-34 expression; E2F1/3: E2F1 and E2F3.</div></div>